Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Universal Ibogaine Inc ( (TSE:IBO) ) has issued an announcement.
Universal Ibogaine Inc. has applied for a management cease trade order (MCTO) due to its inability to meet the filing deadline for its audited financial statements and related documents for the fiscal year ending July 31, 2025. The delay is attributed to limited financial resources, but the company expects to resolve this issue and complete the required filings by the end of January 2026. If granted, the MCTO will restrict trading by the CEO and CFO until the filings are completed, while the public can continue trading the company’s shares. The company will provide bi-weekly updates as per regulatory guidelines until the filings are submitted.
More about Universal Ibogaine Inc
Universal Ibogaine Inc. is a life sciences company focused on transforming addiction treatment through medicalized ibogaine. The company aims to conduct a Canadian clinical trial targeting opioid use disorder and plans to expand its treatment protocol globally through future licensing agreements.
Average Trading Volume: 286,867
Technical Sentiment Signal: Sell
Current Market Cap: C$1.37M
See more data about IBO stock on TipRanks’ Stock Analysis page.